TipRanks on MSN

Bicara sinks after J&J reports head and neck cancer data

Shares of Bicara Therapeutics (BCAX) (BCRX) after moving lower after Johnson & Johnson (JNJ) reported Phase 1b/2 data for amivantamab in patients ...